|
|
|
Insider
Information: |
Gorlin Steve |
Relationship: |
Director |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
2,272,172 |
|
Indirect Shares
|
6,060,392 |
|
|
Direct
Value |
$849,922 |
|
|
Indirect Value
|
$6,485,361 |
|
|
Total
Shares |
8,332,564 |
|
|
Total
Value |
$7,335,283 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
8
|
2
|
Stock
price went up :
|
8
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
8.0
|
-2.0
|
Percentage
Gain/Loss : |
73.9%
|
-158.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medivation Inc |
MDVN |
Director, 10% Owner |
|
0 |
2005-06-08 |
2,657,317 |
Premium* |
|
Mimedx Group Inc |
MDXG |
Director |
2013-05-16 |
11,500 |
2013-05-16 |
886,645 |
Premium* |
|
Point Therapeutics Inc |
POTP |
Director |
|
0 |
2008-02-12 |
2,271,330 |
Premium* |
|
Medovex Corp. |
MDVX |
Director within last 9... |
2017-10-30 |
1,640,704 |
2014-12-18 |
125,000 |
Premium* |
|
Ontrak, Inc |
OTRK |
Director |
2015-10-16 |
450,000 |
2018-06-15 |
100,000 |
Premium* |
|
ImmunityBio, Inc |
IBRX |
Director |
2019-06-06 |
92,592 |
2018-11-29 |
0 |
Premium* |
|
PolarityTE, Inc |
PTE |
Director |
2019-08-06 |
31,018 |
|
0 |
Premium* |
|
Biovie Inc. |
BIVI |
Director |
2023-12-01 |
46,358 |
2020-10-15 |
20,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IBRX |
ImmunityBio, Inc |
Director |
|
2016-05-23 |
4 |
OE |
$0.22 |
$70,019 |
D/D |
324,012 |
729,725 |
0 |
- |
|
MDVX |
Medovex Corp. |
|
|
2016-02-16 |
4 |
B |
$1.81 |
$999,967 |
D/D |
552,041 |
961,503 |
2.39 |
- |
|
MDVX |
Medovex Corp. |
|
|
2016-12-01 |
4 |
B |
$1.75 |
$550,001 |
D/D |
314,286 |
1,018,592 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
|
|
2017-02-09 |
4 |
B |
$1.04 |
$149,999 |
D/D |
144,230 |
1,340,020 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
|
|
2017-06-07 |
4 |
B |
$0.94 |
$28,650 |
D/D |
30,000 |
1,370,020 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
|
|
2017-06-14 |
4 |
B |
$0.97 |
$4,850 |
D/D |
5,000 |
1,375,020 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
|
|
2017-06-28 |
4 |
B |
$0.87 |
$4,370 |
D/D |
5,000 |
1,380,020 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
|
|
2017-08-16 |
4 |
B |
$0.90 |
$180,000 |
D/D |
200,000 |
1,580,020 |
0.01 |
- |
|
MDXG |
Mimedx Group Inc |
Director |
|
2012-03-02 |
4 |
S |
$1.00 |
$250,000 |
I/I |
(250,000) |
1,601,857 |
0 |
- |
|
MDVX |
Medovex Corp. |
DIRECTOR WITHIN LAST 90 DAYS |
|
2017-08-21 |
4 |
B |
$1.25 |
$62,500 |
D/D |
50,000 |
1,630,020 |
0.01 |
- |
|
MDVX |
Medovex Corp. |
Director within last 90 days |
|
2017-10-30 |
4 |
A |
$1.17 |
$12,500 |
D/D |
10,684 |
1,640,704 |
0 |
- |
|
MDXG |
Mimedx Group Inc |
Director |
|
2009-08-04 |
4 |
S |
$0.00 |
$0 |
I/I |
(450,504) |
2,155,987 |
0 |
- |
|
MDXG |
Mimedx Group Inc |
Director |
|
2009-11-19 |
4 |
B |
$0.50 |
$17,500 |
I/I |
35,000 |
2,190,987 |
2.1 |
- |
|
MDVN |
Medivation Inc |
Director |
|
2005-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,212,830 |
2,212,830 |
|
- |
|
POTP |
Point Therapeutics Inc |
Director |
|
2008-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,271,330 |
|
- |
|
MDXG |
Mimedx Group Inc |
Chairman of the BoardOfficer |
|
2008-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,530,844 |
|
- |
|
MDXG |
Mimedx Group Inc |
Chairman of the Board |
|
2008-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
10,530,844 |
10,530,844 |
0 |
- |
|
117 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|